Basic Information
Basic information for MIR9-3HG-218-25aa
Peptide Name MIR9-3HG-218-25aa
Genome Position chr15:89395535-89395609[+]
Species Human
Peptide Sequence MTPSPQLSSPWCSSSSLLLLTAGRA
Peptide Length 25
Unique No (MIR9-3HG-201-25aa,MIR9-3HG-202-25aa-2,MIR9-3HG-203-25aa,MIR9-3HG-205-25aa,MIR9-3HG-212-25aa,MIR9-3HG-213-25aa,MIR9-3HG-214-25aa,MIR9-3HG-219-25aa,MIR9-3HG-220-25aa,MIR9-3HG-221-25aa,MIR9-3HG-222-25aa,MIR9-3HG-224-25aa,MIR9-3HG-225-25aa,MIR9-3HG-226-25aa,MIR9-3HG-227-25aa,MIR9-3HG-228-25aa,MIR9-3HG-229-25aa,MIR9-3HG-233-25aa,MIR9-3HG-240-25aa,MIR9-3HG-241-25aa,MIR9-3HG-242-25aa,MIR9-3HG-244-25aa,MIR9-3HG-246-25aa,MIR9-3HG-247-25aa,MIR9-3HG-248-25aa,MIR9-3HG-249-25aa,MIR9-3HG-251-25aa,MIR9-3HG-252-25aa,MIR9-3HG-253-25aa)
Grand Average of Hydropathicity 0.236
Relative Molecular Mass 3023.38
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000657897;MIR9-3HG-218
Transcript Length 4308
Coding Ability 0.5104
DNA Sequence Corresponding to Peptide ATGACTCCCTCTCCCCAGCTGTCCTCCCCTTGGTGCTCCTCTTCCTCCCTCCTCCTGCTCACAGCAGGCAGGGCC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :